Component
Human beta-cell insulin-granule crystallization
Human beta-cell insulin-granule crystallization
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
SLC30A8-null and R138X beta cells had fewer crystalline insulin granules; glucose-stimulated secretion was not impaired in the tested system.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- curation_topic
- zinc · Zinc
- experimental_condition
- Wild-type cells SLC30A8-null or R138X cells · Human stem-cell-derived SLC30A8-null beta cells Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "SLC30A8-null or R138X cells", "comparator": "Wild-type cells", "endpoint": "Granule crystallization", "effect_direction": "decrease", "combination": "single", "conditions": [{"entity_slug": "human-slc30a8-null-beta-cells", "state": "SLC30A8-null or R138X cells"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed
- limitations
- Separate genotypes, not a combined knockout. Preserved secretion does not establish universal protection.
- primary_references
- SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Diabetes cascade: targeted primary-source supplement · lines 12–12
See claim-local references; curated paraphrases reviewed 2026-09-20. · supports · Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed · source_derived_draft · unverified_draft
SLC30A8-null and R138X beta cells had fewer crystalline insulin granules; glucose-stimulated secretion was not impaired in the tested system. Model: Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed. Limits: Separate genotypes, not a combined knockout. Preserved secretion does not establish universal protection. Primary reference: SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.